Veracyte (VCYT) Other Accumulated Expenses (2012 - 2025)

Veracyte has reported Other Accumulated Expenses for 12 years, with the latest figure at $7000.0 in Q1 2025.

• Other Accumulated Expenses for Q1 2025 came in at $7000.0, down 92.13% year-over-year; the trailing twelve-month figure through Mar 2025 was $7000.0 (down 92.13% YoY), and the FY2024 annual result was $19000.0, down 81.19% from the prior year.
• Other Accumulated Expenses eased to $7000.0 in Q1 2025, from $19000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $241000.0 in Q3 2021 and troughed at $7000.0 in Q1 2025.
• A 5-year average of $129800.0 and a median of $119000.0 in 2023 frame the typical range for Other Accumulated Expenses.
• The widest annual swing landed in 2022, when Other Accumulated Expenses decreased 19.48%; it then plunged 92.13% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $231000.0 in 2021, then declined by 19.48% to $186000.0 in 2022, then sank by 45.7% to $101000.0 in 2023, then plunged by 81.19% to $19000.0 in 2024, then tumbled by 63.16% to $7000.0 in 2025.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $7000.0 in Q1 2025, $19000.0 in Q4 2024, and $53000.0 in Q3 2024.